Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | MAOB | P27338 | 8/20 | 0.35 |
| ▸ | MAOA | P21397 | 7/20 | 0.35 |
| ▸ | KDM1A | O60341 | 5/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 4/20 | 0.35 |
| ▸ | CYP2B6 | P20813 | 3/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.35 |
| ▸ | LMNA | P02545 | 3/20 | 0.35 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.35 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.35 |
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.35 |
| ▸ | HTR1A | P08908 | 1/20 | 0.35 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.35 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.35 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.35 |
| ▸ | HTR2C | P28335 | 1/20 | 0.35 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.35 |
| ▸ | DRD3 | P35462 | 1/20 | 0.35 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL587341 | 0.88 | — | — | |
| SCHEMBL12215973 | 0.71 | TSHR (0.36) | TSHRMAOBMAOAKDM1ACYP2C19 | |
| SCHEMBL12215971 | 0.69 | TSHR (0.31) | TSHRMAOBMAOAKDM1ACYP2C19 | |
| SCHEMBL4267200 | 0.69 | TSHR (0.35) | TSHRMAOBMAOAKDM1ACYP2C19 | |
| SCHEMBL12215976 | 0.69 | GAA (0.40) | TSHRMAOBMAOAKDM1ACYP2C19 | |
| SCHEMBL10022691 | 0.67 | HPGD (0.42) | LMNAKDM4EMAPTTP53 | |
| SCHEMBL20511049 | 0.64 | TSHR (0.31) | TSHRMAOBMAOAKDM1ACYP2C19 | |
| SCHEMBL2031804 | 0.63 | HDAC4 (0.46) | TSHRMAOBMAOAKDM1ACYP2C19 | |
| SCHEMBL31041077 | 0.63 | HDAC4 (0.46) | TSHRMAOBMAOAKDM1ACYP2C19 | |
| SCHEMBL6268220 | 0.63 | MAOB (0.50) | TSHRMAOBMAOAKDM1ACYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 59 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109438914-A | A kind of foamed polyether ether ketone material | 嘉兴博发新型塑料有限公司 | 2019-03-08 | — | — | CN | claimed |
| CN-108290373-A | The reinforcement of foaminess plate supporting material, its manufacturing method and plate | 积水化成品工业株式会社 | 2018-07-17 | — | — | CN | claimed |
| CN-108250669-A | A kind of polyether-ether-ketone expanded material and preparation method thereof | 宜宾天原集团股份有限公司 | 2018-07-06 | — | — | CN | claimed |
| CN-104860908-B | Method for synthesizing BNC105 | 广东颐正达医药科技有限公司 | 2017-03-22 | — | — | CN | claimed |
| CN-104860908-A | Method for synthesizing BNC105 | GUANGDONG YIZHENGDA PHARMACEUTICAL TECHNOLOGY CO LTD | 2015-08-26 | — | — | CN | claimed |
| US-20150150893-A1 | ANDROGRAPHOLIDE ANALOGS AND THEIR USE FOR MEDICATION | LIAONING LIFENG SCIENT & TECHNOLOGY DEV COMPANY LTD (CN) | 2015-06-04 | — | — | US | claimed |
| US-7569580-B2 | Tetrazolo[1,5-a]thieno[2,3-e]pyridine-4-carboxylic acid | RIGEL PHARMACEUTICALS, INC. (US) | 2009-08-04 | — | — | US | claimed |
| CN-1192696-A | Spironolactone and angiotensin 2 antagonist combination therapy for treatment of congestive heart failure | SEARLE & CO (US) | 1998-09-09 | — | — | CN | claimed |
| CN-119528837-A | Synthesis process of 5-phenyl tetrazole | 山东青科农牧发展有限公司 | 2025-02-28 | — | — | CN | disclosed |
| CN-106029746-B | Foamed material | 索尔维特殊聚合物美国有限责任公司 | 2019-06-14 | — | — | CN | disclosed |
| CN-105418526-B | One kind has compound and its application of single sulphenyl tetrazole structure | 杭州伽玛生物科技有限公司 | 2019-02-15 | — | — | CN | disclosed |
| CN-108350583-A | By the power cable for the aluminium that tetrazole compound corrosion inhibitor coats | 普睿司曼股份公司 | 2018-07-31 | — | — | CN | disclosed |
| CN-108290373-A | The reinforcement of foaminess plate supporting material, its manufacturing method and plate | 积水化成品工业株式会社 | 2018-07-17 | — | — | CN | disclosed |
| CN-105793041-B | Original edition of lithographic printing plate and monomer | 爱克发有限公司 | 2018-04-27 | — | — | CN | disclosed |
| CN-1142056-C | Foamed polymer-fiber composite | ����̹�ص¹�˾ | 2004-03-17 | — | — | CN | disclosed |
| CN-1298342-A | Foamed polymer-fiber composite | CERTAIN TEED CORP (US) | 2001-06-06 | — | — | CN | disclosed |
| CN-1189158-A | Novel reagent for synthesizing tetrazole and method for synthesizing tetrazole using same | CHUGOKU KAYAKU (JP) | 1998-07-29 | — | — | CN | disclosed |
| CN-1039324-C | Substituted azacyclo-pyrimidine compounds, their pharmaceutical salts or N-oxides, and their use as anti-inflammatory agents | AMERICAN HOME PROD (US) | 1998-07-29 | — | — | CN | disclosed |
| CN-1175414-A | Method for preparing substd. azacyclopyrimidine compound, its pharmaceutic salt or N-oxide | AMERICAN HOME PROD (US) | 1998-03-11 | — | — | CN | disclosed |
| CN-1134935-A | Herbicidal (1,3,4) oxadiazoles and thiadiazoles | AMERICAN CYANAMID CO (US) | 1996-11-06 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150150893-A1 | ANDROGRAPHOLIDE ANALOGS AND THEIR USE FOR MEDICATION | CYP11B1, CYP51A1, CYP11B2 | TSHR 4310/4885MAOB 3234/4885MAOA 3443/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.